Research Articles
Research articles concerning NAFLD are extracted from PubMed. For each individual article, related therapeutic strategies, targets, drugs and associated diseases in NAFLDkb are presented with knowledge graphs.
stats1
stats2
stats3
stats4
40433 records.
| Article ID | PMID | Source | Title | Publish Year | |
|---|---|---|---|---|---|
| A10221 | 31423319 | BMJ Open Gastroenterol | High potency multistrain probiotic improves liver histology in non-alcoholic fatty liver disease (NAFLD): a randomised, double-blind, proof of concept study. | 2019 | Details |
| A10222 | 31422872 | Trends Endocrinol Metab | Are Lifestyle Therapies Effective for NAFLD Treatment? | 2019 | Details |
| A10223 | 31422074 | Arch Biochem Biophys | CRISPR Cas9-mediated deletion of biliverdin reductase A (BVRA) in mouse liver cells induces oxidative stress and lipid accumulation. | 2019 | Details |
| A10224 | 31422063 | Lancet Diabetes Endocrinol | Metabolic health in the Middle East and north Africa. | 2019 | Details |
| A10225 | 31422033 | Clin Res Hepatol Gastroenterol | Simple blood fibrosis tests reduce unnecessary referrals for specialized evaluations of liver fibrosis in NAFLD and ALD patients. | 2019 | Details |
| A10226 | 31421545 | Int Immunopharmacol | Scoparone alleviates inflammation, apoptosis and fibrosis of non-alcoholic steatohepatitis by suppressing the TLR4/NF-κB signaling pathway in mice. | 2019 | Details |
| A10227 | 31421115 | Chem Biol Interact | Acanthoic acid modulates lipogenesis in nonalcoholic fatty liver disease via FXR/LXRs-dependent manner. | 2019 | Details |
| A10228 | 31421090 | Eur J Pharmacol | Iron chelators in obesity therapy - Old drugs from a new perspective? | 2019 | Details |
| A10229 | 31420528 | J Pharmacol Exp Ther | Withaferin A Improves Nonalcoholic Steatohepatitis in Mice. | 2019 | Details |
| A10230 | 31420525 | J Pharmacol Exp Ther | A Pharmacokinetic Natural Product-Disease-Drug Interaction: A Double Hit of Silymarin and Nonalcoholic Steatohepatitis on Hepatic Transporters in a Rat Model. | 2019 | Details |
| A10231 | 31419571 | Clin Gastroenterol Hepatol | Association Between PNPLA3 rs738409 C>G Variant and Liver-Related Outcomes in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10232 | 31419516 | Pharmacol Ther | The unfolded protein response and hepatic lipid metabolism in non alcoholic fatty liver disease. | 2019 | Details |
| A10233 | 31419514 | J Hepatol | Microbiota-driven gut vascular barrier disruption is a prerequisite for non-alcoholic steatohepatitis development. | 2019 | Details |
| A10234 | 31419466 | Mol Cell Endocrinol | Empaglifozin mitigates NAFLD in high-fat-fed mice by alleviating insulin resistance, lipogenesis and ER stress. | 2019 | Details |
| A10235 | 31419414 | Clin Chim Acta | Fibroblast growth factor 21 in lipid metabolism and non-alcoholic fatty liver disease. | 2019 | Details |
| A10236 | 31419372 | Liver Int | Procoagulant imbalance influences cardiovascular and liver damage in chronic hepatitis C independently of steatosis. | 2019 | Details |
| A10237 | 31418509 | Phytother Res | Fiber and phenolic compounds contribution to the hepatoprotective effects of mango diets in rats fed high cholesterol/sodium cholate. | 2019 | Details |
| A10238 | 31418344 | Curr Vasc Pharmacol | What Does the Future Hold for Non-Alcoholic Fatty Liver Disease and Non-Alcoholic Steatohepatitis? | 2019 | Details |
| A10239 | 31417486 | Front Neurol | Deciphering the Link Between Hyperhomocysteinemia and Ceramide Metabolism in Alzheimer-Type Neurodegeneration. | 2019 | Details |
| A10240 | 31415794 | Mol Cell Endocrinol | Creosote bush-derived NDGA attenuates molecular and pathological changes in a novel mouse model of non-alcoholic steatohepatitis (NASH). | 2019 | Details |
| A10241 | 31415032 | Transplantation | Incidence and Risks for Nonalcoholic Fatty Liver Disease and Steatohepatitis Post-liver Transplant: Systematic Review and Meta-analysis. | 2019 | Details |
| A10243 | 31414497 | J Sci Food Agric | Quercetin administration post-weaning attenuates high-fructose, high-cholesterol diet-induced hepatic steatosis in growing, female, Sprague Dawley rat pups. | 2019 | Details |
| A10244 | 31413575 | Neuropsychiatr Dis Treat | Atypical antipsychotics-induced metabolic syndrome and nonalcoholic fatty liver disease: a critical review. | 2019 | Details |
| A10245 | 31413528 | World J Gastroenterol | Hepatocellular carcinoma in the post-hepatitis C virus era: Should we change the paradigm? | 2019 | Details |
| A10246 | 31413522 | World J Gastroenterol | Hepatocellular carcinoma and metabolic syndrome: The times are changing and so should we. | 2019 | Details |
| A10247 | 31413241 | J Oleo Sci | Elaeagnus mollis Oil Attenuates Non-alcoholic Fatty Disease in High-fat Diet Induced Obese Mice via Modifying the Expression of Lipid Metabolismrelated Genes. | 2019 | Details |
| A10248 | 31412686 | Genes (Basel) | Transcriptomic Analysis of Porcine Granulosa Cells Overexpressing Retinol Binding Protein 4. | 2019 | Details |
| A10249 | 31412267 | Eur J Pharmacol | Liraglutide improves insulin sensitivity in high fat diet induced diabetic mice through multiple pathways. | 2019 | Details |
| A10250 | 31411894 | Am J Physiol Gastrointest Liver Physiol | Digoxin improves steatohepatitis with differential involvement of liver cell subsets in mice through inhibition of PKM2 transactivation. | 2019 | Details |
| A10252 | 31410156 | Exp Ther Med | Role and effective therapeutic target of gut microbiota in NAFLD/NASH. | 2019 | Details |
| A10253 | 31410151 | Exp Ther Med | Association between abdominal obesity and liver steatosis and fibrosis among patients with chronic hepatitis B measured by Fibroscan. | 2019 | Details |
| A10254 | 31409773 | Cell Death Dis | mTOR direct crosstalk with STAT5 promotes de novo lipid synthesis and induces hepatocellular carcinoma. | 2019 | Details |
| A10255 | 31409765 | Exp Mol Med | A protective mechanism of probiotic Lactobacillus against hepatic steatosis via reducing host intestinal fatty acid absorption. | 2019 | Details |
| A10256 | 31409057 | Cells | iPla2β Deficiency Suppresses Hepatic ER UPR, Fxr, and Phospholipids in Mice Fed with MCD Diet, Resulting in Exacerbated Hepatic Bile Acids and Biliary Cell Proliferation. | 2019 | Details |
| A10257 | 31408914 | Mol Nutr Food Res | In Utero One-Carbon Metabolism Interplay and Metabolic Syndrome in Cardiovascular Disease Risk Reduction. | 2019 | Details |
| A10258 | 31408586 | Mol Nutr Food Res | Lycopene Alleviates Obesity-Induced Inflammation and Insulin Resistance by Regulating M1/M2 Status of Macrophages. | 2019 | Details |
| A10259 | 31408567 | Hepatol Res | Identification of two microRNA nodes as potential cooperative modulators of liver metabolism. | 2019 | Details |
| A10260 | 31408437 | J Clin Invest | Nuclear envelope-localized torsinA-LAP1 complex regulates hepatic VLDL secretion and steatosis. | 2019 | Details |
| A10261 | 31408278 | IUBMB Life | Silencing of lncRNA SNHG20 delays the progression of nonalcoholic fatty liver disease to hepatocellular carcinoma via regulating liver Kupffer cells polarization. | 2019 | Details |
| A10262 | 31408176 | J Clin Endocrinol Metab | Hepatic Fatty Acid Balance and Hepatic Fat Content in Humans With Severe Obesity. | 2019 | Details |
| A10263 | 31406519 | J Med Life | Relevance between Helicobacter pylori Infection and Non-Alcoholic Fatty Liver Disease in Birjand, Iran. | 2019 | Details |
| A10264 | 31406506 | J Biol Eng | Targeting CYP4A attenuates hepatic steatosis in a novel multicellular organotypic liver model. | 2019 | Details |
| A10265 | 31406138 | Sci Rep | TGR(mREN2)27 rats develop non-alcoholic fatty liver disease-associated portal hypertension responsive to modulations of Janus-kinase 2 and Mas receptor. | 2019 | Details |
| A10266 | 31406127 | Sci Rep | The TM6SF2 E167K genetic variant induces lipid biosynthesis and reduces apolipoprotein B secretion in human hepatic 3D spheroids. | 2019 | Details |
| A10267 | 31406044 | Nihon Yakurigaku Zasshi | [The role of iron overload in the progression of nonalcoholic steatohepatitis (NASH)]. | 2019 | Details |
| A10268 | 31405697 | Diabetes Metab Syndr | Partitioning of radiological, stress and biochemical changes in pre-diabetic women subjected to Diabetic Yoga Protocol. | 2019 | Details |
| A10270 | 31405127 | Nutrients | Sex-Specific Differences in Fat Storage, Development of Non-Alcoholic Fatty Liver Disease and Brain Structure in Juvenile HFD-Induced Obese Ldlr-/-.Leiden Mice. | 2019 | Details |
| A10271 | 31404666 | Clin Gastroenterol Hepatol | Increasing Liver Fat Is Associated With Incident Cardiovascular Risk Factors. | 2019 | Details |
| A10272 | 31404663 | Clin Gastroenterol Hepatol | Identification and Characterization of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10274 | 31402655 | J Agric Food Chem | Novel Fluorescence-Based Method To Characterize the Antioxidative Effects of Food Metabolites on Lipid Droplets in Cultured Hepatocytes. | 2019 | Details |
| A10275 | 31402618 | Ann Clin Transl Neurol | Abnormal fatty acid metabolism is a core component of spinal muscular atrophy. | 2019 | Details |
| A10276 | 31402538 | Liver Int | CONTROL: A randomized phase 2 study of obeticholic acid and atorvastatin on lipoproteins in nonalcoholic steatohepatitis patients. | 2019 | Details |
| A10277 | 31402253 | Transplant Proc | A Changing Etiologic Scenario in Liver Transplantation: A Single-Center Cohort Study From Turkey. | 2019 | Details |
| A10278 | 31402248 | Transplant Proc | The Utility of Noninvasive Scoring Systems for Prediction of Hepatic Steatosis in Liver Transplantation Donor Candidates. | 2019 | Details |
| A10279 | 31401392 | Biomed Pharmacother | Alpha-naphthoflavone attenuates non-alcoholic fatty liver disease in oleic acid-treated HepG2 hepatocytes and in high fat diet-fed mice. | 2019 | Details |
| A10280 | 31401389 | Cell Calcium | Deranged hepatocyte intracellular Ca2+ homeostasis and the progression of non-alcoholic fatty liver disease to hepatocellular carcinoma. | 2019 | Details |
| A10281 | 31401193 | EBioMedicine | Simulation of gastric bypass effects on glucose metabolism and non-alcoholic fatty liver disease with the Sleeveballoon device. | 2019 | Details |
| A10283 | 31400075 | Kaohsiung J Med Sci | The relationship between nonalcoholic fatty liver disease and pediatric congenital hypothyroidism patients. | 2019 | Details |
| A10284 | 31399619 | Sci Rep | Evaluation of AGP Fucosylation as a Marker for Hepatocellular Carcinoma of Three Different Etiologies. | 2019 | Details |
| A10285 | 31399173 | Transplant Proc | Range of Normal Serum Aminotransferase Levels in Liver Transplant Recipients. | 2019 | Details |
| A10286 | 31399137 | BMC Res Notes | Effect of curcumin supplementation on serum expression of select cytokines and chemokines in a female rat model of nonalcoholic steatohepatitis. | 2019 | Details |
| A10287 | 31399032 | Lipids Health Dis | Correlation of triglyceride to high-density lipoprotein cholesterol ratio with nonalcoholic fatty liver disease among the non-obese Chinese population with normal blood lipid levels: a retrospective cohort research. | 2019 | Details |
| A10288 | 31398468 | Biochim Biophys Acta Mol Basis Dis | Vibrational spectroscopy-based quantification of liver steatosis. | 2019 | Details |
| A10289 | 31398386 | J Am Coll Surg | Liver Resection for Nonalcoholic Fatty Liver Disease-Associated Hepatocellular Carcinoma. | 2019 | Details |
| A10290 | 31398325 | Mol Cell | Landscape of Intercellular Crosstalk in Healthy and NASH Liver Revealed by Single-Cell Secretome Gene Analysis. | 2019 | Details |
| A10291 | 31397685 | Clin Transl Gastroenterol | Multicenter Validation Study of a Diagnostic Algorithm to Detect NASH and Fibrosis in NAFLD Patients With Low NAFLD Fibrosis Score or Liver Stiffness. | 2019 | Details |
| A10292 | 31397492 | Clin Exp Pharmacol Physiol | Insulin-like growth factor binding protein 7 accelerates hepatic steatosis and insulin resistance in non-alcoholic fatty liver disease. | 2019 | Details |
| A10293 | 31396538 | J Diabetes Res | Visfatin Induces Inflammation and Insulin Resistance via the NF-κB and STAT3 Signaling Pathways in Hepatocytes. | 2019 | Details |
| A10294 | 31396337 | Am J Transl Res | Swimming prevents nonalcoholic fatty liver disease by reducing migration inhibitory factor through Akt suppression and autophagy activation. | 2019 | Details |
| A10295 | 31394881 | Nutrients | Non-Alcoholic Fatty Liver Disease is Associated with Higher Metabolic Expenditure in Overweight and Obese Subjects: A Case-Control Study. | 2019 | Details |
| A10296 | 31394730 | Cells | Current Status in Testing for Nonalcoholic Fatty Liver Disease (NAFLD) and Nonalcoholic Steatohepatitis (NASH). | 2019 | Details |
| A10297 | 31394020 | Am J Transplant | The decreasing predictive power of MELD in an era of changing etiology of liver disease. | 2019 | Details |
| A10298 | 31393852 | JCI Insight | Adipocyte JAK2 mediates spontaneous metabolic liver disease and hepatocellular carcinoma. | 2019 | Details |
| A10299 | 31393851 | J Clin Invest | Degradation of splicing factor SRSF3 contributes to progressive liver disease. | 2019 | Details |
| A10300 | 31393787 | Am J Physiol Gastrointest Liver Physiol | Exogenous PP2A inhibitor exacerbates the progression of nonalcoholic fatty liver disease via NOX2-dependent activation of miR21. | 2019 | Details |
| A10302 | 31393374 | Medicine (Baltimore) | Analysis of human leukocyte antigen allele polymorphism in patients with non alcoholic fatty liver disease. | 2019 | Details |
| A10303 | 31392821 | Liver Int | Lysosomal acid lipase activity and liver fibrosis in the clinical continuum of non-alcoholic fatty liver disease. | 2019 | Details |
| A10304 | 31392349 | Cell Mol Life Sci | Lipophagy mediated carbohydrate-induced changes of lipid metabolism via oxidative stress, endoplasmic reticulum (ER) stress and ChREBP/PPARγ pathways. | 2019 | Details |
| A10305 | 31391806 | Gastroenterol Hepatol (N Y) | Screening for Nonalcoholic Fatty Liver Disease in the Primary Care Clinic. | 2019 | Details |
| A10306 | 31391765 | World J Gastroenterol | Importance of fatigue and its measurement in chronic liver disease. | 2019 | Details |
| A10307 | 31391764 | World J Gastroenterol | Role of sodium-glucose co-transporter-2 inhibitors in the management of nonalcoholic fatty liver disease. | 2019 | Details |
| A10308 | 31391339 | JCI Insight | The hepatokine Tsukushi is released in response to NAFLD and impacts cholesterol homeostasis. | 2019 | Details |
| A10309 | 31390852 | Turk J Med Sci | Association between PPARGC1A single nucleotide polymorphisms and increased risk of nonalcoholic fatty liver disease among Iranian patients with type 2 diabetes mellitus | 2019 | Details |
| A10310 | 31390551 | Cell Metab | Generation of Human Fatty Livers Using Custom-Engineered Induced Pluripotent Stem Cells with Modifiable SIRT1 Metabolism. | 2019 | Details |
| A10311 | 31390281 | J Med Food | Elucidation of the Metabolic and Transcriptional Responses of an Oriental Herbal Medicine, Bangpungtongseong-san, to Nonalcoholic Fatty Liver Disease in Diet-Induced Obese Mice. | 2019 | Details |
| A10314 | 31389309 | Thyroid | Nonalcoholic Fatty Liver Disease and Hypercholesterolemia: Roles of Thyroid Hormones, Metabolites, and Agonists. | 2019 | Details |
| A10315 | 31389294 | Epigenetics | Non-alcoholic fatty liver disease (NAFLD) is associated with dynamic changes in DNA hydroxymethylation. | 2019 | Details |
| A10316 | 31388695 | Diabetologia | Genetic inactivation of the LIGHT (TNFSF14) cytokine in mice restores glucose homeostasis and diminishes hepatic steatosis. | 2019 | Details |
| A10317 | 31388628 | Hepatol Commun | Body Composition and Genetic Lipodystrophy Risk Score Associate With Nonalcoholic Fatty Liver Disease and Liver Fibrosis. | 2019 | Details |
| A10318 | 31388627 | Hepatol Commun | Associations Between Body Fat, Muscle Mass, and Nonalcoholic Fatty Liver Disease: A Population-Based Study. | 2019 | Details |
| A10319 | 31388626 | Hepatol Commun | Mortality Risk Detected by Atherosclerotic Cardiovascular Disease Score in Patients With Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10320 | 31388625 | Hepatol Commun | Liver Proliferation Is an Essential Driver of Fibrosis in Mouse Models of Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10321 | 31388624 | Hepatol Commun | Genetic Polymorphisms Implicated in Nonalcoholic Liver Disease or Selected Other Disorders Have No Influence on Drug-Induced Liver Injury. | 2019 | Details |
| A10322 | 31388398 | World J Hepatol | Rise of sodium-glucose cotransporter 2 inhibitors in the management of nonalcoholic fatty liver disease. | 2019 | Details |
| A10323 | 31388096 | Int J Obes (Lond) | Circulating microbiota-derived metabolites: a "liquid biopsy? | 2019 | Details |
| A10324 | 31387736 | Lancet Gastroenterol Hepatol | Management of metabolic syndrome and cardiovascular risk after liver transplantation. | 2019 | Details |
| A10325 | 31387306 | Int J Mol Sci | High-Fat Feeding in Time-Dependent Manner Affects Metabolic Routes Leading to Nervonic Acid Synthesis in NAFLD. | 2019 | Details |
| A10326 | 31387260 | Antioxidants (Basel) | Inhibition of Heme Oxygenase Antioxidant Activity Exacerbates Hepatic Steatosis and Fibrosis In Vitro. | 2019 | Details |
| A10327 | 31387232 | Int J Environ Res Public Health | DNA Hydroxymethylation at the Interface of the Environment and Nonalcoholic Fatty Liver Disease. | 2019 | Details |
| A10328 | 31387231 | Antioxidants (Basel) | Lycopene Modulates Pathophysiological Processes of Non-Alcoholic Fatty Liver Disease in Obese Rats. | 2019 | Details |